Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > New Corporate Presentation
View:
Post by AlfredSisley on Feb 17, 2021 1:23pm

New Corporate Presentation

XB3-001 Ph1 in 1Q 2022.

BTI finally/hopefully going to start saving some folks!

Nasdaq by year end?
Comment by MineDigger on Feb 18, 2021 5:58am
As noted y JDavenport in his https://stoxcomm.com/ 2021-02-17 10:57 update the new Corpresentation has some slides deleted and other changes. To see the changes I suggest uploading the January one and this new Feb one to draftable.com (for those old hands around, it is a pretty visual diff for pdfs and other docs). In fact I already have and it seems that I can share the link, apparently they ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities